Barbara Burrall is a Dermatology physician affiliated with University of California Davis Medical Center. OpenAlex indexes 45 publications with 756 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
32.5%Azole Antifungal25%Ketoconazole100%Part D≥37 patientsLincosamide Antibacterial4.1%Clindamycin Phosphate100%Part D<11 patients+ 1 more class in this area
Dermatology
30%Interleukin-4 Receptor alpha Antagonist15.3%Dupixent Syringe63%Dupixent Pen37%Part D<11 patientsCorticosteroid14.7%Triamcinolone Acetonide100%Part D≥28 patientsCancer & immunology
18.1%Nucleoside Metabolic Inhibitor10%Fluorouracil100%Part D≥28 patientsInterleukin-23 Antagonist4.7%Skyrizi Pen100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1985–1986 per NIH RePORTER. The latest:
- CELLULAR PATHWAYS OF LIPOXYGENATION OF ARACHIDONIC ACID
University of California San Francisco
FY1986K11AI000668 - CELLULAR PATHWAYS OF LIPOXYGENATION OF ARACHIDONIC ACID
University of California San Francisco
FY1985K11AI000668
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Longevity in dermatologists-why do so many dermatologists live so long?
Dermatology Online Journal
2025 - Trichodysplasia spinulosa: a presentation of polyomavirus infection in immunosuppressed patients
Dermatology Online Journal
2022
Similar KOLs
Other experts from the same institution or the same specialty.
David Asmuth, MD
University of California Davis Medical Center
Helen Chew, MD
University of California Davis Medical Center
Ai‐Ming Yu
University of California Davis Medical Center
Burton L. Wise
University of California Davis Medical Center
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”